Nephrolyx GmbH

Nephrolyx provides precise and rapid kidney function measurement. Offering hospitals and labs an In-Vitro Diagnostic Test and a digital platform for detection of renal diseases with unmatched accuracy, Nephrolyx helps physicians to facilitate optimal treatment plans for patients, particularly in nephrology, oncology, transplantation, and ICU settings. The Nephrolyx test, intended for the quantitative determination of serum iohexol concentration, utilizes Ultra-High-Performance-Liquid Chromatography and Ultra-Violet light. This proprietary technology not only enhances treatment outcomes for kidney patients but also significantly improves overall healthcare system performance due to its low component cost.